CC

Commodore Capital Portfolio holdings

AUM $1.5B
1-Year Est. Return 149.78%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+149.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$546M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$23M
2
+$22M
3
+$21.4M
4
ALKS icon
Alkermes
ALKS
+$13.6M
5
REPL icon
Replimune Group
REPL
+$12.1M

Top Sells

1
+$332M
2
+$142M
3
+$97.6M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$93.9M
5
NUVL icon
Nuvalent
NUVL
+$83.8M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SABS icon
26
SAB Biotherapeutics
SABS
$219M
$16.5M 1.1%
4,401,500
REPL icon
27
Replimune Group
REPL
$626M
$13.9M 0.92%
+1,425,000
IKT icon
28
Inhibikase Therapeutics
IKT
$241M
$11.1M 0.74%
5,397,488
CTNM
29
Contineum Therapeutics
CTNM
$506M
$9.33M 0.62%
+816,326
AVTX icon
30
Avalo Therapeutics
AVTX
$309M
$8.77M 0.58%
483,000
RAPT
31
DELISTED
RAPT Therapeutics
RAPT
$8.47M 0.56%
+250,000
LONA
32
LeonaBio Inc
LONA
$70M
$3.52M 0.23%
+464,398
DRUG
33
Bright Minds Biosciences
DRUG
$707M
$1.47M 0.1%
18,851
-481,149
TNGX icon
34
Tango Therapeutics
TNGX
$2.45B
– –
-1,500,000
VRDN icon
35
Viridian Therapeutics
VRDN
$2.9B
– –
-3,200,000
VTGN icon
36
VistaGen Therapeutics
VTGN
$25M
– –
-1,575,000
PCSC
37
Perceptive Capital Solutions
PCSC
$124M
– –
-750,000
AGIO icon
38
Agios Pharmaceuticals
AGIO
$1.62B
– –
-2,338,287
APGE icon
39
Apogee Therapeutics
APGE
$5.06B
– –
-290,000
CDTX
40
DELISTED
Cidara Therapeutics
CDTX
– –
-585,000
ENTA icon
41
Enanta Pharmaceuticals
ENTA
$389M
– –
-800,000
CBIO
42
Crescent Biopharma
CBIO
$352M
– –
-450,829
MRUS
43
DELISTED
Merus
MRUS
– –
-3,525,000
1
2